Elizabeth Raymond


  • close

    Can we eliminate the mifepristone visit in medical abortion?

    Elizabeth Raymond Gynuity Health Projects, New York, USA - eraymond@gynuity.org

    The requirement to present to a clinician in person to receive abortifacient drugs is problematic for some women. Eliminating this requirement would enable intriguing new service delivery options, including provision of medical abortion in non-traditional, non-clinical venues and provision by prescription or mail. This presentation will review data regarding the utility of examination and ultrasound prior to medical abortion and will discuss potential alternative approaches to assess eligibility that could be used over the telephone or internet.